Kristen Harrington-Smith
Senior Vice President & Chief Commercial Officer, ImmunoGen
Ms. Harrington-Smith has more than 20 years of pharmaceutical experience across oncology, rare diseases and primary care. She currently serves as Senior Vice President & Chief Commercial Officer at ImmunoGen, a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer. Prior to this, she held numerous leadership roles at Novartis Pharmaceuticals, including VP & Head of U.S. Hematology, where she led the commercial teams responsible for a portfolio of therapies in both benign and malignant hematologic diseases and positioned the company for multiple consecutive product launches. Before that, she was VP & Head of U.S. CAR-T Franchise, where she was responsible for the successful launch of the first chimeric antigen receptor t-cell therapy, including creating the go-to-market model for this novel treatment modality. Previously, she was responsible for the global commercial strategy for Novartis Cell & Gene Therapies, and, prior to that, she held the role of Head of Marketing, Multiple Sclerosis Franchise. She holds an M.B.A from the Kenan-Flagler Business School at the University of North Carolina, Chapel Hill and a B.S. in psychology from Williams College.